![]() ![]() |
Strategic Consulting and Organizational Change for the Biomedical Industry Developing strategic and business growth initiatives for pharmaceutical, biotechnology, device, diagnostic, R&D, information management and healthcare provider organizations.
33 Witherspoon St., Suite 200 |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
|
PGI provides management consulting services to the healthcare
industry. We assist pharmaceutical, medical device, equipment,
biotechnology and diagnostic companies and other healthcare-focused
companies with business strategy, development and growth and
organizational change requirements. PGI has a special franchise in
identifying new technology and product opportunities and engineering
alliances, joint ventures and acquisition transactions with
multinational enterprises. PGI is also an advisor of choice for
European biomedical enterprises seeking to enter the United States market.
PGI services include PGI helps its client companies to discover and pursue new initiatives that will materially and rapidly enhance valuation and profitable revenue growth. Included in these initiatives might be acquisitions, alliances and joint ventures as well as internal organic programs of both an operational and financial nature.PGI utilizes in its work its established relationships at senior levels in the industry. PGI has particular expertise in the healthcare systems and markets of Western Europe and has managed transaction projects in countries around the globe including East Asia, South America, Eastern Europe and Russia as well as more developed regions.. Among PGI’s past and present clients are Bristol-Myers Squibb,
Baxter International, Glaxo, Johnson & Johnson, Mallinckrodt,
Orion Pharmaceuticals, Scandinavian Life Sciences Venture Fund, First Ventury
Fund (Germany), EGIS Pharmaceuticals, ICON Pharmaceuticals, Strata Biosciences, CADUS
Pharmaceuticals, Delsys Inc., Mass General Hospital, Beth Israel Deaconess Medical Center, North Shore Health System, U.S. State Department, Vialogy Corp,
International Genomics Inc., Arthur D. Little, Cambridge Health Economics
Group, Atlantic Health, Universal Health Communications, David Sarnoff
Research Center, Orchid Biocomputer, Ixion Biotechnology, Immuno-
Designed Molecules, Creative Biomolecules, Carmel Pharma, Affimed,
Pangene Corporation, Cosmos Pharmaceuticals, Biofem Inc., Neoplasia,
Inc., Cyanotech Corporation and Cantab Pharmaceuticals.
PGI also provides its services pro bono to the Personalized Medicine Coalition, CaPCURE Foundation (prostate cancer) and the Harvard School of Public Health. Our goal is bottom-line success for our clients derived from creative solutions
which PGI partners in the implementation and makes happen. To see
some examples of such achievements click on
PGI Success Stories.
Other similar stories of the success of PGI's unique approach to
helping its clients achieve their most challenging aspirations can
be described and the ways we may be able to do the same for you can
be explained by your contacting our offices at the above location.
![]() For all-natural hair, skin and nail products, visit our affiliated company, Xenna Corporation at ![]() |